Front Endocrinol (Lausanne) 15:1431292
We do not prescribe compounded versions of semaglutide or tirzepatide
The MHRA continues to monitor the safety profiles of these medications, and healthcare professionals should remain alert to emerging evidence regarding long-term outcomes
Freezing can degrade the formulation so do not freeze it
Common week one experiences include mild appetite reduction that comes and goes, slight changes in how food tastes or appeals, occasional mild nausea, particularly after larger meals, and a subtle sense of fullness that arrives earlier during meals than usual
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association